Literature DB >> 2122630

Parenteral nutrition in preterm neonates with and without carnitine supplementation.

L E Larsson1, R Olegård, B M Ljung, A Niklasson, A Rubensson, G Cederblad.   

Abstract

The effects of carnitine supplementation on fat and glucose metabolism and carnitine balance were studied in 12 preterm neonates receiving full or partial parenteral nutrition (PN) for 5 to 21 days. The gestational age ranged from 27 to 32 weeks and the birth weight from 790 to 2090 g. The neonates were assigned at random to receive either L-carnitine 10 mg/kg (n = 6) or saline (n = 6). In the carnitine group, increased concentrations in plasma of total and free carnitine were observed. Less than 50% of the given dose was recovered in urine. In the placebo group no changes in the total plasma carnitine concentration were seen. In all neonates plasma triglycerides, free fatty acids, glycerol, alanine, 3-hydroxybutyrate (BOB), glucose and lactate were measured at predetermined intervals. The only significant difference between the groups was higher BOB-concentrations in the carnitine group 2 days after the start of parenteral nutrition. Elevated BOB concentrations are an indicator of improved fatty acid oxidation in the carnitine group. In this study, only a temporary effect of the carnitine supplementation was found.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122630     DOI: 10.1111/j.1399-6576.1990.tb03132.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  3 in total

Review 1.  L-Carnitine.

Authors:  J H Walter
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

Review 2.  Carnitine supplementation for preterm infants with recurrent apnea.

Authors:  M Kumar; N S Kabra; B Paes
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

3.  Carnitine deficiency in OCTN2-/- newborn mice leads to a severe gut and immune phenotype with widespread atrophy, apoptosis and a pro-inflammatory response.

Authors:  Srinivas Sonne; Prem S Shekhawat; Dietrich Matern; Vadivel Ganapathy; Leszek Ignatowicz
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.